SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

$DOG.X is trending as a Bitcoin-native meme coin launched via the Runes protocol, generating buzz for its fair distribution and strong community. Discussions highlight its potential to drive utility and transaction volume on the Bitcoin network, with many touting it as a leader in the current cycle. Community members are actively promoting its unique position compared to other meme coins and speculating about potential exchange listings.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending amid speculation around a potential licensing deal with AstraZeneca, with community members discussing the impact of recent trial data and a possible buyout. Some investors are analyzing trial endpoints and revenue potential, while others are comparing SMMT to competitors like IOVA. The community is closely watching for further developments and official announcements.

ProShares Trust - ProShares Short Dow30 -1x Shares

ProShares Short Dow30

$DOG is trending as the Bitcoin memecoin gains traction within the crypto community, with many touting its fair launch and strong community backing. Conversation highlights its potential to become the meme face of Bitcoin and draw comparisons to other popular memecoins. Community members are emphasizing its organic growth and decentralized nature.

DOVU

DOVU.X is trending as the community highlights its staking rewards and potential in the Real World Asset (RWA) space, particularly due to its "Trust Operating System." Recent news around partnerships and deals related to carbon credits and ecological projects may be acting as a catalyst. Community members are actively discussing its association with Hedera and potential for significant growth.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as discussions revolve around its potential integration with established platforms like XRP and its role in tokenizing real-world assets (RWA). Community members are actively speculating on entry points, potential profits, and where to purchase the token, while also debating its legitimacy and long-term prospects.

K9 Finance, a Shibarium-based LSD platform, offers core DeFi services and acts as an official validator. Rewarding $KNINE holders with $BONE for block validation, it aims to drive DeFi adoption via the 'Roundtable of Dogs' DAO, which governs treasury and roadmap decisions.

K9 Finance DAO

K9 Finance DAO ($KNINE.X) is trending due to the upcoming K9 Quest Airdrop and its role as a key player in Shibarium's DeFi ecosystem, offering liquid staking for $BONE.X. The community is actively discussing staking strategies, DAO governance, and ways to earn rewards through Bonecrusher and ShibaSwap integration. With its innovative tri-token system and focus on real yield, K9 Finance is positioned to drive DeFi adoption on Shibarium.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to a significant land sale agreement, potentially boosting its NAV. The community is discussing the stock's low float and potential for a substantial price increase, with some highlighting potential squeeze dynamics. Bullish sentiment appears to be building, driven by the company's real estate assets and upcoming shareholder meeting.

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases. The company was founded by Andrew May, Luciano Marraffini, Rodolphe Barrangou, Nessan Bermingham, Rachel Haurwitz, Erik Sontheimer, Jennifer Doudna, and Derrick Rossi in May 2014 and is headquartered in Cambridge, MA.

Intellia Therapeutics Inc

NTLA is trending amid discussions about its gene therapy pipeline and recent safety data from a Phase 3 trial; the community is weighing the long-term potential against short-term risks. Some traders are focusing on analyst ratings and potential for a sector rotation, while others discuss potential acquisition scenarios and ARK Invest's position in the stock. Overall, the conversation revolves around the balance between gene editing's promise and the volatility of clinical trials.

Voyager Technologies, Inc. engages in the defense technology and space solutions. It operates through the following segments: Defense & National Security, Space Solutions, and Starlab Space Stations. The Defense & National Security segment consists of innovative mission-critical solutions to protect dynamic and contested domains. The Space Solutions segment consists of space infrastructure, advanced space technology, science systems and mission services. The Starlab Space Stations segment consists of a commercial space station. The company was founded by Dylan Taylor and Matthew Kuta on August 15, 2019 and is headquartered in Denver, CO.

Voyager Technologies Inc. - Ordinary Shares - Class A

Voyager Technologies Inc

VOYG is trending as investors are digesting the implications of its recent inclusion in the Russell 2000 Index and various analyst ratings. The community is actively discussing the company's potential in the defense and space sectors, particularly its connections to initiatives like Golden Dome and partnerships with companies like Palantir. While some see long-term potential, others express concerns about the stock's performance since its IPO and its current valuation.

Chewy, Inc. operates as an online retailer of pet food and other pet-related products and services. It supplies pet medications, food, treats and other pet-health products and services for dogs, cats, fish, birds, small pets, horses, and reptiles. It has a portfolio of pet healthcare offerings that includes Chewy Pharmacy, Connect with a Vet, and CarePlus, an exclusive suite of pet-first insurance and wellness plans. The company was founded by Ryan Cohen and Michael Day in September 2011 and is headquartered in Plantation, FL.

Chewy Inc - Ordinary Shares - Class A

Chewy Inc

Chewy is trending as investors digest the latest earnings report and guidance, with community members actively discussing the company's market position and future growth prospects. While some express disappointment, others point to positive aspects of the report and reiterate long-term bullish sentiment, viewing any price drops as buying opportunities. Technical analysis and analyst ratings are also contributing to the ongoing conversation around $CHWY.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Beyond Launch: Rocket Lab's Push for Semiconductor Dominance

RKLB doubles down on semiconductor production to strengthen its role in space and defense technologies.

L3Harris Wins Deal to Equip Poland's F-16s With Viper Shield EW System

LHX to equip Poland's F-16s with its Viper Shield EW system, reinforcing its edge in electronic warfare solutions.

Poland Selects L3Harris Electronic Warfare System for F-16 Fleet

The government of Poland has selected L3Harris Technologies (NYSE: LHX) to provide its Viper Shield electronic warfare (EW) system for the countrys F-16 Viper upgrade program. Poland will purchase...

KTOS or LHX: Which Stock Stands Stronger in Today's Defense Boom?

Rising defense spending puts KTOS and LHX in focus as both enjoy significant traction in next-gen defense tech.

Howmet vs. L3Harris: Which Aerospace & Defense Stock Should You Bet On?

HWM outpaces LHX with stronger aerospace momentum, higher growth estimates and robust shareholder returns.

Will Trump's New Executive Order Fast-Track Lockheed's Space Ambitions?

Trump's executive order streamlining space regulations could accelerate Lockheed's Orion, ULA launches and broader space ambitions. 


L3Harris Technologies (LHX) announced on Wednesday that the U.S. Space Force successfully launched its Navigation Technology Satellite-3 from Cape Canaveral Space Force Station on a United Launch Alliance Vulcan rocket.The NTS-3, built by L3Harris, is the Department of Defense’s first experimental navigation satellite system in nearly 50 years, the company noted. It is also the first fully reprogrammable Positioning, Navigation and Timing (PNT) satellite, the firm said, adding that it is also smaller and lighter than traditional PNT satellites. The satellites’ payload technology is modular and scalable and can be configured to fly on different satellite buses.“The need for accurate and uninterrupted PNT has never been more essential to our warfighters who operate in GPS-denied environments,” <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.l3harris.com/newsroom/press-release/2025/08/us-space-force-successfully-launches-l3harris-built-nts-3-satellite">said</a> Ed Zoiss, President of Space and Airborne Systems at L3Harris.On Stocktwits, retail sentiment around <a href="https://stocktwits.com/symbol/LHX/sentiment">LHX</a> trended in the ‘bearish’ territory over the past 24 hours, while message volume remained at ‘low’ levels.L3Harris delivered NTS-3 three times faster and at lower cost than similar programs, the company said. Once on-orbit, the satellite will perform experiments to shape future U.S. space-based PNT capabilities. The Vulcan rocket carrying the satellite lifted off on August 12 at 8:56 p.m. EDT. It marked the first National Security Space Launch aboard the Vulcan rocket developed by ULA, a joint venture between Boeing and Lockheed Martin.Vulcan has launched two other missions since its debut in January 2024, but neither carried military satellites.LHX stock is up by 28% this year and by about 18% over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/x4-pharmaceuticals-stock-rises-on-closing-of-upsized-offering/chrCgB1Rd99">X4 Pharmaceuticals Stock Rises On Closing Of Upsized Offering, But Brokerage Lowers Price Target</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a smartphone displays the logo of L3Harris Technologies Inc. in front of a screen showing stock market data on July 19, 2025 in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

L3Harris Announces Successful Launch Of Experimental Navigation Satellite System

The NTS-3 is the Department of Defense’s first experimental navigation satellite system in nearly 50 years, the company said.

Equity

The NTS-3 is the Department of Defense’s first experimental navigation satellite system in nearly 50 years, the company said.


The Zacks Analyst Blog Highlights Lockheed Martin's, Boeing and L3Harris Technologies

Lockheed's space unit rebounds with Q2 growth, eyeing long-term gains from Artemis funding and classified contracts despite near-term delays.

From Short-Term Struggles to Long-Term Wins: Lockheed's Space Story

Lockheed's Space segment rebounds with 4% Q2 growth, eyeing long-term gains despite Artemis delays and earlier revenue declines.


California-based air taxi company Joby Aviation, Inc. (JOBY) said on Friday that it is exploring opportunities to develop a new vertical take-off and landing aircraft for defense purposes with L3Harris Technologies (LHX).<a href="https://stocktwits.com/symbol/JOBY">JOBY</a> shares rose 6% in morning trade at the time of writing. On Stocktwits, retail sentiment around JOBY trended in the ‘bearish’ territory, coupled with ‘low’ message volume.<figure class="image"><img style="aspect-ratio:625/63;" src="https://news.stocktwits-cdn.com/Screenshot_2025_08_01_at_9_54_18_AM_png_b472e76547.webp" alt="JOBY's Sentiment Meter and Message Volume as of 9:50 a.m. ET on Aug. 1, 2025 | Source: Stocktwits" width="625" height="63"><figcaption>JOBY's Sentiment Meter and Message Volume as of 9:50 a.m. ET on Aug. 1, 2025 | Source: Stocktwits</figcaption></figure>A Stocktwits user sounded skeptical following the announcement.<stembedurl>https://stocktwits.com/dymaxion19/message/623368359</stembedurl>Another user believes the stock could see more dilution.<stembedurl>https://stocktwits.com/Bull_2020/message/623370301</stembedurl>Joby <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.jobyaviation.com/news/joby-lhx-collaboration/">said</a> that the new aircraft class could be used for a range of low-altitude support use cases.While testing of the aircraft will start in the fall this year, operational demonstrations are planned for 2026. It will bring together Joby’s commercial aircraft development program with L3Harris’ expertise on platform missionization, including sensors and effectors.Gas turbine hybrid vertical take-off and landing (VTOL) aircraft are designed for low altitude missions and can be operated with a crew or fully autonomously, the company noted.The company added that it is actively developing a gas turbine hybrid powertrain for its current S4 five-seater eVTOL air taxi aircraft.JPMorgan on Friday raised its price target on Joby Aviation to $7 from $5 while keeping an ‘Underweight’ rating on the shares. However, the new price target implies nearly 58% downside to the stock’s closing price on Thursday.The firm said that it views the recent outperformance in the electric vertical take-off and landing sector as "irrational exuberance."While President Trump's executive order is a positive signal around the government's support for eVTOL, any further developments are unlikely to impact company earnings materially in the near term, the analyst told investors in a research note.JPMorgan thinks significant cash burn and further revenue push-outs should be better reflected in shares.JOBY stock has more than doubled its value this year and tripled over the past 12 months.Read also: <a href="https://stocktwits.com/news-articles/markets/equity/moderna-ceo-attributes-full-year-revenue-guidance-reduction-to-timing-of-shipments/chr3CyaRdbK">Moderna CEO Attributes Full-Year Revenue Guidance Reduction To Timing Of Shipments: Retail Pins Hopes On Pipeline After Q2 Beat</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Joby Aviation, Inc. is displayed on a smartphone screen with a stock market chart in the background, on May 04, 2025, in Chongqing, China. (Photo illustration by Cheng Xin/Getty Images)

Joby Stock Surges Post L3Harris Collaboration, JPMorgan Price Target Hike: Retail’s Skeptical

While testing of the new aircraft will start in the fall this year, operational demonstrations are planned for 2026.

L3Harris Technologies, Inc. engages in the provision of defense and commercial technologies across the air, land, sea, space, and cyber domains. It operates through the following segments: Space and Airborne Systems, Integrated Mission Systems, Communication Systems, and Aerojet Rocketdyne. The Space and Airborne Systems segment provides full mission solutions as a prime and subsystem integrator in the space, airborne and cyber domains. The Integrated Mission Systems segment focuses on the differentiated mission capabilities and prime systems integration for the air, land and sea domains. The Communication Systems segment enables warfighters across all domains with solutions critical to mission success even in the most contested environments. The Aerojet Rocketdyne segment includes propulsion, power and armament products and systems to U.S. government, including the DoD, National Aeronautics and Space Administration (“NASA”) and major aerospace and defense prime contractors. The company was founded in 1890 and is headquartered in Melbourne, FL.

LHX
L3Harris Technologies Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest LHX News

LHX L3Harris Technologies Inc